In the title, abstract, and abbreviations footnote of the article above [Dvir E, Friedman JE, Lee JY, Koh JY, Younis F, Raz S, Shapiro I, Hoffman A, Dahan A, Rosenberg G, Angel I, Kozak A, and Duvdevani (2006) J Pharmacol Exper Ther 318: 1248–1256], the chemical composition of DP-155 was misreported. The corrected portion of the composition, with changes noted in bold, appears as follows: {6-[1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indolyl acetamido]hexanoyl}.
The chemical structure of DP-155 as shown in Fig. 1 is correct.
The online version of this article has been corrected in departure from the print version.
The authors regret this error and apologize for any confusion or inconvenience it may have caused.
- The American Society for Pharmacology and Experimental Therapeutics